Journal profile · Psychiatry
Journal of Psychopharmacology
ISSN 0269-8811 · eISSN 1461-7285 · SAGE Publications Ltd · ENGLAND · Monthly · Founded 1987
Journal of Psychopharmacology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.3; hybrid open access; APC about USD 4,400; review 3–8 weeks (community reports); community-reported acceptance: fairly hard; 164 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Psychopharmacology is published by SAGE Publications Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment and Treatment of Major Depression, together about 30.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
Source: LetPub
Research area (LetPub): Psychiatry
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neurotransmitter Receptor Influence on BehaviorNeuroscience13.3%
- Schizophrenia research and treatmentMedicine8.8%
- Treatment of Major DepressionMedicine8.4%
- Psychedelics and Drug StudiesPsychology6.2%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.2%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics5.3%
- Cannabis and Cannabinoid ResearchMedicine4.3%
- Memory and Neural MechanismsNeuroscience4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Psychiatry | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.3LetPub ·
- CiteScore 2026-06
- 10.3LetPub ·
- SJR 2026-06
- 1.68LetPub ·
- SNIP 2026-06
- 1.54LetPub ·
- h-index
- 106LetPub ·
- h-index
- 169OpenAlex ·
- i10-index
- 2,934OpenAlex ·
- 2-year mean citedness
- 4.35OpenAlex ·
- Self-citation rate
- 5.7%LetPub ·
- Share of gold OA articles
- 46.88%LetPub ·
Volume
- Articles per year
- 145LetPub ·
Articles by year OpenAlex count · 4,785 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 138 | 79 | 73 |
| 2025 | 164 | 95 | 493 |
| 2024 | 127 | 89 | 1,301 |
| 2023 | 117 | 78 | 2,060 |
| 2022 | 138 | 82 | 4,051 |
| 2021 | 138 | 79 | 3,559 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,400 / GBP 3,226 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- SAGE Publications Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1987
- ISSN
- 0269-8811
- Electronic ISSN
- 1461-7285
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Psychopharmacology
What CAS zone is Journal of Psychopharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Psychopharmacology is in Zone 3 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy / Clinical Neurology / Neurosciences / Psychiatry. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Psychopharmacology?
The latest impact factor listed by LetPub is 5.3; CiteScore 10.3, h-index 169.
How long does peer review take at Journal of Psychopharmacology?
Authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Psychopharmacology?
According to LetPub and DOAJ records, Journal of Psychopharmacology is indexed in SCIE and Scopus.
Is Journal of Psychopharmacology open access, and what is the APC?
Journal of Psychopharmacology is a hybrid journal. For open-access publication: APC about USD 4,400.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .